相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Dysplastic nevus part I: Historical perspective, classification, and epidemiology
Roman Drozdowski et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2023)
Clinicopathologic and genetic characterization of invasive melanoma with BRAF V600K mutation: A study of 16 cases
Keisuke Goto et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2023)
PRAME Is a Novel Target of Tumor-Intrinsic Gas6/Axl Activation and Promotes Cancer Cell Invasion in Hepatocellular Carcinoma
Viola Hedrich et al.
CANCERS (2023)
Immunohistochemical expression of PRAME in 485 cases of epithelial tubo-ovarian tumors
Adam Safanda et al.
VIRCHOWS ARCHIV (2023)
Standardized Computer-Assisted Analysis of PRAME Immunoreactivity in Dysplastic Nevi and Superficial Spreading Melanomas
Elias A. T. Koch et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Preferentially expressed Antigen in MElanoma immunohistochemistry as an adjunct for evaluating ambiguous melanocytic proliferation
Antonin Fattori et al.
HUMAN PATHOLOGY (2022)
Analysis of interobserver reproducibility in grading dysplastic nevi: Results of the application of the 2018 World Health Organization grading criteria
Ovgu Aydin Ulgen et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2022)
Genome-Scale DNA Methylation Analysis Identifies Repeat Element Alterations that Modulate the Genomic Stability of Melanocytic Nevi
Mitchell S. Stark et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)
Shared Gene Expression and Immune Pathway Changes Associated with Progression from Nevi to Melanoma
Elizabeth S. Borden et al.
CANCERS (2022)
Cutaneous Melanomas: A Single Center Experience on the Usage of Immunohistochemistry Applied for the Diagnosis
Costantino Ricci et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
PRAME Immunoexpression in 275 Cutaneous Melanocytic Lesions: A Double Institutional Experience
Gerardo Cazzato et al.
DIAGNOSTICS (2022)
PRAME immunohistochemistry as an adjunct for diagnosis and histological margin assessment in lentigo maligna
Sarah E. Gradecki et al.
HISTOPATHOLOGY (2021)
The utility of PRAME staining in identifying malignant transformation of melanocytic nevi
Mary E. Lohman et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2021)
The utility of PRAME immunohistochemistry in the evaluation of challenging melanocytic tumors
Ahmed K. Alomari et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2021)
The PRAME family of cancer testis antigens is essential for germline development and gametogenesis
Chandlar H. Kern et al.
BIOLOGY OF REPRODUCTION (2021)
Diffuse PRAME Expression Is Highly Specific for Thin Melanomas in the Distinction from Severely Dysplastic Nevi but Does Not Distinguish Metastasizing from Non-Metastasizing Thin Melanomas
Maximilian Gassenmaier et al.
CANCERS (2021)
Immunohistochemistry for PRAME in the Distinction of Nodal Nevi From Metastatic Melanoma
Cecilia Lezcano et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)
The 2018 World Health Organization Classification of Cutaneous, Mucosal, and Uveal Melanoma Detailed Analysis of 9 Distinct Subtypes Defined by Their Evolutionary Pathway
David E. Elder et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2020)
The role of the cancer testis antigen PRAME in tumorigenesis and immunotherapy in human cancer
Yichi Xu et al.
CELL PROLIFERATION (2020)
Comparison of Immunohistochemistry for PRAME With Cytogenetic Test Results in the Evaluation of Challenging Melanocytic Tumors
Cecilia Lezcano et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)
PRAMEexpression in melanocytic proliferations with intermediate histopathologic or spitzoid features
Shyam S. Raghavan et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2020)
Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway
Hanzhang Zhu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Improving classification of melanocytic nevi: Association of BRAF V600E expression with distinct histomorphologic features
Maija Kiuru et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
A Comprehensive Immunologic Portrait of Triple-Negative Breast Cancer
Zhixian Liu et al.
TRANSLATIONAL ONCOLOGY (2018)
PRAME Expression in Melanocytic Tumors
Cecilia Lezcano et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2018)
PRAME as diagnostic marker and as regulator for cell fate decisions in germ cell cancers
Nina Neuhaus
BRITISH JOURNAL OF CANCER (2016)
Analysis of interobserver reproducibility in grading histological patterns of dysplastic nevi
Aretha Brito Nobre et al.
ANAIS BRASILEIROS DE DERMATOLOGIA (2013)
Knock-Down of PRAME Increases Retinoic Acid Signaling and Cytotoxic Drug Sensitivity of Hodgkin Lymphoma Cells
Stefanie Kewitz et al.
PLOS ONE (2013)
Leucine-rich repeat protein PRAME: expression, potential functions and clinical implications for leukaemia
Frances Wadelin et al.
MOLECULAR CANCER (2010)
Hypomethylation of PRAMS is responsible for its aberrant overexpression in human malignancies
Tino Schenk et al.
GENES CHROMOSOMES & CANCER (2007)
Dysplastic naevi with moderate to severe histological dysplasia: a risk factor for melanoma
A. R. Shors et al.
BRITISH JOURNAL OF DERMATOLOGY (2006)
The human tumor antigen repressor of retinoic acid PRAME is a dominant receptor signaling
MT Epping et al.
CELL (2005)